Thomas R. Cannell
Overview
Thomas R. Cannell received an average of $2M in total compensation, including $415K in salary, at Eleven Biotherapeutics from 2018 to 2023. Thomas Cannell also received an average of $3M at Orexigen Therapeutics between 2015 and 2016.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2016
- 2015
Eleven BiotherapeuticsFormer President and Chief Executive Officer
Eleven BiotherapeuticsFormer President and Chief Executive Officer
Eleven BiotherapeuticsPresident and Chief Executive Officer
Eleven BiotherapeuticsPresident and Chief Executive Officer
Eleven BiotherapeuticsPresident and Chief Executive Officer
Eleven BiotherapeuticsPresident and Chief Executive Officer
Orexigen TherapeuticsExecutive Vice President, Chief Operating Officer and President of Global Commercial Products
Orexigen TherapeuticsExecutive Vice President, Chief Operating Officer and President of Global Commercial Products
Source: SEC filings on April 29, 2024, April 28, 2023, April 28, 2022, March 25, 2021, March 30, 2020, April 30, 2019, and May 30, 2017.
Related executives
We found 29 more executives who work or worked at Eleven Biotherapeutics and Orexigen Therapeutics.
Steven Kelly
Eleven Biotherapeutics
Chief Executive Officer
Richard Morris
Eleven Biotherapeutics
Chief Financial Officer
Michael Klichinsky
Eleven Biotherapeutics
Chief Scientific Officer
Monica Forbes
Eleven Biotherapeutics
Chief Financial Officer
Mark Sullivan
Eleven Biotherapeutics
General Counsel
Glen MacDonald
Eleven Biotherapeutics
Chief Technology Officer
Mark Sullivan
Eleven Biotherapeutics
General Counsel
Stephen Hurly
Eleven Biotherapeutics
Chief Executive Officer
News
Eleven Biotherapeutics CEO Steven Kelly receives $3.5M in 2023
April 29, 2024
Eleven Biotherapeutics CEO Thomas Cannell's 2022 pay falls 72% to $1.4M
April 28, 2023
Eleven Biotherapeutics CEO Thomas Cannell's 2021 pay jumps 189% to $4.9M
April 28, 2022
Eleven Biotherapeutics CEO Thomas Cannell's 2020 pay jumps 21% to $1.7M
March 25, 2021
Eleven Biotherapeutics CEO Thomas Cannell's 2019 pay falls 30% to $1.4M
March 30, 2020
Eleven Biotherapeutics CEO Thomas Cannell receives $2M in 2018
April 30, 2019